E-ISSN 2636-834X
 

Original Research 


Efficacy of group behavioral activation treatment as supplemental treatment to pharmacotherapy in inpatients with depressive disorders

Samad Fereidooni, Banafsheh Gharaei, Behrooz Birashk, Ali Sahraeian, Seyed Mohammad Davood Hoseini.

Abstract
Objective: It is important to consider history of dealing with depression as it evolved from pure behavioral approaches that predate behavioral activation. Current behavioral activation adds an idiographic and functional approaches, which explores client’s needs, goals and environmental contingencies that support depressive behaviors and moods. The aim of this study is to evaluate efficacy of Group Behavioral Activation Treatment (GBAT) as a supplemental treatment to pharmacotherapy in inpatients suffering from depressive disorders.
Methods: This is a clinical trial. We included 24 patients with depressive disorders (according to SCID-I), who were admitted to Shiraz Psychiatric Hospital in summer 2010. They were randomly divided into three groups: intervention, control, and placebo. All three groups prescribed their usual pharmacological treatment. Additionally, first group was treated with GBAT. In order to control the efficacy of therapist’s attention, third group watched video-movie as well. All participants completed Beck Depression Inventory-II (BDI-II) and Behavioral Activation for Depression Scale (BADS).
Results: According to the results of the analysis of variance for repeated measures: all 3 groups showed same decrease in post and 2 mounts follow-up in BDI-II, however there was no significant difference among groups. Nevertheless, based on the results of analysis for BDI-II, it is indicated that behavioral activation therapy has been effective in decreasing depression of patients (F=11.27; p=0.001). Results indicated that based on the analysis of BADS, patients’ depression has significantly decreased (F=105.97; p=0.001).
Conclusions: Our research findings indicate that using the GBAT as a supplemental treatment for depressed inpatients can increase the effectiveness of medication therapy. Small sample size and cautions in the generalization of the present findings to be noted.

Key words: Group Behavioral Activation Treatment (GBAT), pharmacotherapy, depressive disorders, inpatients, supplemental treatment.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Samad Fereidooni
Articles by Banafsheh Gharaei
Articles by Behrooz Birashk
Articles by Ali Sahraeian
Articles by Seyed Mohammad Davood Hoseini
on Google
on Google Scholar


REFERENCES
1. Akiskal Hagop S. Mood Disorders: Clinical Features. In: Sadock Benjamin J, Sadock Virginia A, Ruiz Pedro. Kaplan & Sadock's Comprehensive Textbook of Psychiatry. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2009. P.1693-1734.
2. Ferster CB. A functional analysis of depression. American Psychologist. 1973;28:857-870. [DOI via Crossref]    [Pubmed]   
3. Lewinsohn, P. M. A behavioral approach to depression. In R. J. Friedman, & M. M. Katz (Eds.), The psychology of depression: Contemporary theory and research. New York: John Wiley & Sons; 1974.
4. Martell CR, Addis ME, Jacobson NS. Depression in context: Strategies for guided action. 1st ed. New York: Norton; 2001.
5. Carvalho John P, Hopko Derek R. Behavioral theory of depression: Reinforcement as a mediating variable between avoidance and depression. Journal of Behavior Therapy and Experimental Psychiatry. 2011;42:154-62. [DOI via Crossref]    [Pubmed]   
6. Skinner BF. Science and human behavior. New York: The Free Press; 1953.
7. Lewinsohn PM, Antonuccio DO, Breckenridge JS, Teri L. The Coping with Depression course. Eugene, OR: Castalia; 1984. [PMC Free Fulltext]   
8. Hopko Derek R, Armento Maria EA, Cantu Melissa S, Chambers Laura L, Lejuez CW. The use of daily diaries to assess the relations among mood state, overt behavior, and reward value of activities. Behaviour Research and Therapy. 2003;41:1137-48. [DOI via Crossref]   
9. Lewinsohn PM, Graf M. Pleasant activities and depression. Journal of Consulting and Clinical Psychology. 1973;41:261-8. [DOI via Crossref]   
10. Lewinsohn P, Libet J. Pleasant events, activity schedules, and depression. Journal of Abnormal Psychology. 1972;79:291-295. [DOI via Crossref]    [Pubmed]   
11. MacPhillamy DJ, Lewinsohn PM. Depression as a function of levels of desired and obtained pleasure. Journal of Abnormal Psychology.1974;83:651-7. [DOI via Crossref]   
12. Pim Cuijpers, Annemieke van Straten, Lisanne Warmerdam. Behavioral activation treatments of depression: A meta-analysis. Clinical Psychology Review. 2007;27:318-26. [DOI via Crossref]   
13. Hopkoa DR, Lejuez CW, Ruggiero Kenneth J, Eifert Georg H. Contemporary behavioral activation treatments for depression: Procedures, principles, and progress. Clinical Psychology Review. 2003;23:699-717. [DOI via Crossref]   
14. Hopko DR, Lejuez CW, McNeil DW, Hopko SD. A brief behavioral activation treatment for depression: An adjunct to pharmacotherapy. Poster presented at the 3rd International Conference on Bipolar Disorder, Pittsburgh, PA. Bipolar Disorders. 1999;1:36.
15. Hopko DR, LePage J, Hopko SD, Lejuez CW, McNeil DW, Roberts H. A brief behavioral activation treatment for depression: Implementation and efficacy within an inpatient setting. Poster presented at the 33rd annual meeting of the Association for the advancement of Behavior Therapy, Toronto, Canada; 1999.
16. Lejuez CW, Hopko DR, LePage JP, Hopko SD, McNeil DW. A brief behavioral activation treatment for depression. Cognitive and Behavioral Practice. 2001;8:164-75. [DOI via Crossref]   
17. Lejuez CW, Hopko Derek R, Hopko Sandra D. A Brief Behavioral Activation Treatment for Depression: Treatment Manual. Behaviour Modification. 2001;25:255-86. [DOI via Crossref]   
18. Goodarzi Nasser, Besharat Mohammad Ali, Rostami Reza, Bahrami Ehsan Hadi, Lavasani Masoud Golamali. The effectivness of group contracting and behavioral activation therapy on opioid substance use disorders. Contemporary Psychology. 2008,3,3-14. (In Persian)
19. Amiri Mehdi, Yekeyazdan Dost Rokhsareh, Tabatabaei Seyed Mahmood. The effectiveness of group behavioral activation therapy in reducing the severity of depression symptoms and enhance general health and quality of life In clients at therapeutic community center. circuit treatment community center maddjoyan. Research on addiction. 2009;9:101-114. (In Persian)
20. Veale David. Behavioural activation for depression. Advances in Psychiatric Treatment. 2008;14: 29-36. [DOI via Crossref]   
21. Gollan Jackie, Atlis Mera, Coner O, Megan Marlow. Behavioral Activation: Group Treatment for Depression. (unpublished manuscript). 2003.
22. Kanter JW, Mulick PS, Busch AM, Berlin KS, Martell CR. The Behavioral Activation for Depression Scale (BADS): Psychometric properties and factor structure. Journal of Psychopathology and Behavioral Assessment. 2006;29:191-202. [DOI via Crossref]   
23. Kanter Jonathan W, Rusch Laura C, Busch Andrew M, Sedivy Sonya K. Validation of the Behavioral Activation for Depression Scale (BADS) in a Community Sample with Elevated Depressive Symptoms. Psychopathology and Behavioral Assessment. 2009;31:36-42. [DOI via Crossref]   
24. Kanter JW, Mulick P. Basic science foundations and new applications of behavioral activation. Symposium accepted for the annual meeting of the Association of Behavioral and Cognitive Therapies. 2007.
25. Mohammadi Abolfazl, Amiri Mehdi. Behavioral Activation for Depression Scale: Psychometric Properties and Confirmatory factor analysis for Persian version. Iranian Journal of Psychiatry and Clinical Psychology (IJPCP). 2010;16:65-73. (In Persian)
26. Beck AT, Steer RA, Brown GK. Manual for the BDI-II. San Antonio, TX: The Psychological Corporation. 1996.
27. Nezu AM, Ronan GF, Meadows EA, McClure KS. Practitioner's guide to empirically based measures of depression. New York: Kluwer; 2000.
28. Beck AT, Steer RA. Manual for the Beck Depression Inventory. San Antonio, TX. 1993.
29. Biggs JT, Wylie LT, Ziegler VE. Validity of the Zung Self-rating Depression Scale. Br J Psychiatry. 1978;132:381-5. [DOI via Crossref]    [Pubmed]   
30. Beck AT, Steer RA, Carbin M. Psychometric properties of the Beck depression inventory: Twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77-100. [DOI via Crossref]   
31. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess. 1996;67:588-97. [DOI via Crossref]    [Pubmed]   
32. Richter P, Werner J, Heerlein A, Kraus A, Sauer H. On the validity of the Beck depression Inventory: A review. Psychopathology. 1998;31:160-8. [DOI via Crossref]   
33. Zung WWK. Zung Self-rating Depression Scale (Zung SDS). in Handbook of psychiatric measures. Washington, DC, APA, 2000: 534-537.
34. National Institute for Clinical Excellence (NICE). Depression: Management of depression in primary and secondary care. UK: National Clinical Practice Guideline Number 23; 2004. 358 p.
35. Hopko DR, Lejuez CW, Lepage JP, Hopko SD, McNeil DW. A brief behavioral activation treatment for depression; a randomized pilot trial within an inpatient psychiatric hospital. Behavior Modification. 2003;27:458-69. [DOI via Crossref]   

How to Cite this Article
Pubmed Style

Samad Fereidooni, Banafsheh Gharaei, Behrooz Birashk, Ali Sahraeian, Seyed Mohammad Davood Hoseini. Efficacy of group behavioral activation treatment as supplemental treatment to pharmacotherapy in inpatients with depressive disorders. PBS. 2015; 5(3): 104-12. doi:10.5455/jmood.20140913061428


Web Style

Samad Fereidooni, Banafsheh Gharaei, Behrooz Birashk, Ali Sahraeian, Seyed Mohammad Davood Hoseini. Efficacy of group behavioral activation treatment as supplemental treatment to pharmacotherapy in inpatients with depressive disorders. https://www.pbsciences.org/?mno=162353 [Access: April 05, 2022]. doi:10.5455/jmood.20140913061428


AMA (American Medical Association) Style

Samad Fereidooni, Banafsheh Gharaei, Behrooz Birashk, Ali Sahraeian, Seyed Mohammad Davood Hoseini. Efficacy of group behavioral activation treatment as supplemental treatment to pharmacotherapy in inpatients with depressive disorders. PBS. 2015; 5(3): 104-12. doi:10.5455/jmood.20140913061428



Vancouver/ICMJE Style

Samad Fereidooni, Banafsheh Gharaei, Behrooz Birashk, Ali Sahraeian, Seyed Mohammad Davood Hoseini. Efficacy of group behavioral activation treatment as supplemental treatment to pharmacotherapy in inpatients with depressive disorders. PBS. (2015), [cited April 05, 2022]; 5(3): 104-12. doi:10.5455/jmood.20140913061428



Harvard Style

Samad Fereidooni, Banafsheh Gharaei, Behrooz Birashk, Ali Sahraeian, Seyed Mohammad Davood Hoseini (2015) Efficacy of group behavioral activation treatment as supplemental treatment to pharmacotherapy in inpatients with depressive disorders. PBS, 5 (3), 104-12. doi:10.5455/jmood.20140913061428



Turabian Style

Samad Fereidooni, Banafsheh Gharaei, Behrooz Birashk, Ali Sahraeian, Seyed Mohammad Davood Hoseini. 2015. Efficacy of group behavioral activation treatment as supplemental treatment to pharmacotherapy in inpatients with depressive disorders. Psychiatry and Behavioral Sciences, 5 (3), 104-12. doi:10.5455/jmood.20140913061428



Chicago Style

Samad Fereidooni, Banafsheh Gharaei, Behrooz Birashk, Ali Sahraeian, Seyed Mohammad Davood Hoseini. "Efficacy of group behavioral activation treatment as supplemental treatment to pharmacotherapy in inpatients with depressive disorders." Psychiatry and Behavioral Sciences 5 (2015), 104-12. doi:10.5455/jmood.20140913061428



MLA (The Modern Language Association) Style

Samad Fereidooni, Banafsheh Gharaei, Behrooz Birashk, Ali Sahraeian, Seyed Mohammad Davood Hoseini. "Efficacy of group behavioral activation treatment as supplemental treatment to pharmacotherapy in inpatients with depressive disorders." Psychiatry and Behavioral Sciences 5.3 (2015), 104-12. Print. doi:10.5455/jmood.20140913061428



APA (American Psychological Association) Style

Samad Fereidooni, Banafsheh Gharaei, Behrooz Birashk, Ali Sahraeian, Seyed Mohammad Davood Hoseini (2015) Efficacy of group behavioral activation treatment as supplemental treatment to pharmacotherapy in inpatients with depressive disorders. Psychiatry and Behavioral Sciences, 5 (3), 104-12. doi:10.5455/jmood.20140913061428